Form 4: Alkami Technology CFO Exercises Options and Sells Shares Under 10b5-1 Plan

Alkami Technology's Chief Financial Officer, W. Bryan Hill, exercised stock options and sold 100,000 shares of common stock on December 16, 2024, under a pre-arranged trading plan.

Summary

• W. Bryan Hill, the Chief Financial Officer of Alkami Technology, Inc., executed a transaction involving the company's stock on December 16, 2024.
• Mr. Hill exercised stock options to acquire 100,000 shares of common stock at a price of $2.34 per share.
• Simultaneously, he sold 100,000 shares of common stock at a weighted average price of $39.7685 per share.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 11, 2024.
• Following these transactions, Mr. Hill directly owns 353,841 shares of Alkami Technology common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the sale of shares by the CFO could raise concerns, the fact that it was done under a pre-arranged 10b5-1 plan mitigates the negative impact. The exercise of options at a low price and sale at a higher price is a positive for the executive.

Positives

• The exercise of options at a low price and subsequent sale at a significantly higher price indicates a potential profit for the CFO.
• The use of a 10b5-1 trading plan suggests the transactions were pre-planned and not based on insider information.

Negatives

• The sale of 100,000 shares by a key executive could be perceived negatively by the market, potentially signaling a lack of confidence in the company's future performance, although this is mitigated by the 10b5-1 plan.

Risks

• The market may react negatively to the sale of shares by a high-ranking executive, even if it is part of a pre-planned trading strategy.
• There is a risk of increased volatility in the stock price due to the large volume of shares sold.

Industry Context

This type of transaction is common for executives who receive stock options as part of their compensation. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including technology firms like Alkami.
• Similar transactions are frequently reported by executives at companies such as nCino, Inc. (NCNO) and Jack Henry & Associates, Inc. (JKHY), which are also in the financial technology sector.
• The price range of the sale, between $39.37 and $40.19, is within the typical range for market transactions of this type.

Stakeholder Impact

• Shareholders may react to the sale of shares by the CFO, potentially causing short-term price fluctuations.
• Employees may view the transaction as a normal part of executive compensation.

Key Dates

Keywords

Form 4, insider trading, stock options, 10b5-1 plan, share sale, Alkami Technology, ALKT, W. Bryan Hill, CFO